InMed (INM) Fundamental Analysis: Revenue, Earnings & Valuation

4.51 / 10

Netural

Fundamental rating is neutral with a 4.5/10 score. Inventory turnover (2.93) and accounts receivable turnover (12.09) are strong, yet income‑tax‑to‑profit (0%) and PB‑ROE (-0.95) are weak, suggesting selective investment.

Analysis Checks(8/10)

Revenue-MV

Value0.94

Score3/3

Weight42.10%

1M Return8.83%

Total operating revenue (YoY growth rate %)

Value7.50

Score2/3

Weight2.24%

1M Return0.58%

Inventory turnover ratio

Value2.93

Score2/3

Weight-2.65%

1M Return-0.66%

Accounts receivable turnover ratio

Value12.09

Score2/3

Weight-2.37%

1M Return-0.65%

PB-ROE

Value-0.95

Score1/3

Weight22.32%

1M Return5.22%

Income tax / Total profit (%)

Value0.00

Score0/3

Weight-5.38%

1M Return-1.54%

Fixed assets turnover ratio

Value4.41

Score2/3

Weight-3.78%

1M Return-1.01%

Interest coverage ratio (EBIT / Interest expense) (%)

Value34.91

Score2/3

Weight-2.67%

1M Return-0.73%

Cost of sales ratio (%)

Value65.47

Score2/3

Weight-2.62%

1M Return-0.74%

Asset-MV

Value-0.55

Score2/3

Weight52.81%

1M Return9.91%

Is INM fundamentally strong?

INM scores 4.51/10 on fundamentals and holds a Fair valuation at present. Backed by its -32.62% ROE, -170.07% net margin, -0.27 P/E ratio, 0.21 P/B ratio, and 76.70% earnings growth, these metrics solidify its Netural investment rating.